<?xml version="1.0" encoding="UTF-8"?>
<ref id="B108-vetsci-02-00456">
 <label>108.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gil</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Leal</surname>
    <given-names>R.O.</given-names>
   </name>
   <name>
    <surname>McGahie</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Sepulveda</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Duarte</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Niza</surname>
    <given-names>M.M.</given-names>
   </name>
   <name>
    <surname>Tavares</surname>
    <given-names>L.</given-names>
   </name>
  </person-group>
  <article-title>Oral recombinant feline interferon-omega as an alternative immune modulation therapy in FIV positive cats: Clinical and laboratory evaluation</article-title>
  <source>Res. Vet. Sci.</source>
  <year>2014</year>
  <volume>96</volume>
  <fpage>79</fpage>
  <lpage>85</lpage>
  <pub-id pub-id-type="doi">10.1016/j.rvsc.2013.11.007</pub-id>
  <?supplied-pmid 24332273?>
  <pub-id pub-id-type="pmid">24332273</pub-id>
 </element-citation>
</ref>
